Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin B12 Supplement to Slow Brain Atrophy in Older Diabetic Outpatients
ChiCTR-OCH-14005010Phase 4Not yet recruiting
- Sponsor
- Prince of Wales Hospital
- Start
- Aug 2014
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of cyanocobalamin in type 2 diabetes mellitus (T2DM), cerebral atrophy and confusion, sponsored by Prince of Wales Hospital. Primary endpoint: Whole brain volume. Planned start Aug 2014; status: not yet recruiting.
02
Drugs
cyanocobalamin
03
Conditions
type 2 diabetes mellitus (T2DM)cerebral atrophyconfusion
Beyond the preview
Go deeper on ChiCTR-OCH-14005010.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OCH-14005010.